Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on S Pregabalin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced nitro-reduction pathway for S-Pregabalin offers safer scalable manufacturing and significant cost reduction in API production without high-pressure carbon monoxide.
Patent CN102382785B reveals a novel Morganella morganii strain for high-purity Pregabalin intermediate production, offering significant cost and supply chain advantages.
Patent CN114164198B enables enzymatic synthesis of chiral intermediates. This route offers substantial cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Novel solvent-free route for 4-isobutyl pyrrolidone ensures high purity and cost efficiency for pregabalin supply chains.
Patent CN102382785A details a novel biocatalytic route for high-purity pregabalin intermediates. Discover cost-effective manufacturing and supply chain advantages.
Patent CN103626668A offers high-efficiency resolution for S-pregabalin. Enhances supply chain reliability and reduces manufacturing costs significantly.
Novel ammonium sulfate process for 3-isobutylglutaric acid. Enhances purity and supply chain reliability for pregabalin intermediate production globally.
Patent CN110803994B reveals a green DES-based route for pregabalin intermediates. Discover how this technology enables cost reduction in API manufacturing and reliable supply.
Novel metal halide catalysis eliminates high-pressure hydrogenation risks. Delivers high-purity lactam compounds with significant cost reduction in API manufacturing and enhanced supply chain reliability for global partners.
Patent CN101848905A details a novel enantioselective route for (S)-pregabalin using D-mannitol, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN109851543B reveals a cost-effective route for S-pregabalin lactam using acidic oxides. Achieve >99% purity for pharmaceutical impurity standards.
Patent CN103626668B reveals a novel resolution method for S-Pregabalin offering high purity and scalable supply chain advantages for pharmaceutical manufacturers.